{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:07:23Z","timestamp":1790626043467,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG030653"],"award-info":[{"award-number":["AG030653"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG041718"],"award-info":[{"award-number":["AG041718"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AG025204"],"award-info":[{"award-number":["P01 AG025204"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AG005133"],"award-info":[{"award-number":["P50 AG005133"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37 AG025516"],"award-info":[{"award-number":["R37 AG025516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32 AG000181"],"award-info":[{"award-number":["T32 AG000181"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.neurobiolaging.2013.09.040","type":"journal-article","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T20:15:47Z","timestamp":1380831347000},"page":"802-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Markers of cholesterol transport are associated with amyloid deposition in the brain"],"prefix":"10.1016","volume":"35","author":[{"given":"Timothy M.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar L.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhobert W.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ilyas","family":"Kamboh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff D.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Klunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester A.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth E.","family":"Snitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"DeKosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis H.","family":"Kuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","article-title":"Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain","volume":"260","author":"Bjorkhem","year":"2006","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(00)01466-X","article-title":"Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases","volume":"293","author":"Bretillon","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2013.01.015","article-title":"Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches","volume":"71","author":"Cohen","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cct.2006.02.007","article-title":"The Ginkgo Evaluation of Memory (GEM) Study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia","volume":"27","author":"DeKosky","year":"2006","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to Alzheimer's disease: cholesterol and beyond","volume":"12","author":"Di Paolo","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/abio.1995.1110","article-title":"Determination of cholesterols oxidation products in human plasma by isotope dilution-mass spectroscopy","volume":"225","author":"Dzeletovic","year":"1995","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","article-title":"The Mini-Mental State Examination","volume":"40","author":"Folstein","year":"1983","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1212\/WNL.0b013e318211c352","article-title":"Plasma apolipoprotein E and Alzheimer disease risk: the AIBL Study of Aging","volume":"76","author":"Gupta","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/JAD-2012-111460","article-title":"Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease","volume":"30","author":"Hughes","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3233\/JAD-2012-121585","article-title":"Brain cholesterol metabolism, oxysterols, and dementia","volume":"33","author":"Hughes","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib15","doi-asserted-by":"crossref","first-page":"e44260","DOI":"10.1371\/journal.pone.0044260","article-title":"Plasma based markers of [11C] PiB-PET brain amyloid burden","volume":"7","author":"Kiddle","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1042\/BST0381021","article-title":"Links between ApoE, brain cholesterol metabolism, tau and amyloid beta-peptide in patients with cognitive impairment","volume":"38","author":"Leoni","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/00365510802651858","article-title":"Oxysterols as markers of neurological disease: a review","volume":"69","author":"Leoni","year":"2009","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","article-title":"Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular dementia patients","volume":"41","author":"Lutjohann","year":"2000","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/ana.23797","article-title":"In\u00a0vivo assessment of amyloid-\u03b2 deposition in non-demented very elderly subjects","author":"Mathis","year":"2013","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003160.pub2","article-title":"Statins for the prevention of dementia","volume":"2","author":"McGuinness","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007514.pub2","article-title":"Statins for the treatment of dementia","volume":"8","author":"McGuinness","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib23","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00001756-200006260-00030","article-title":"Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease","volume":"26","author":"Papassotiropoulus","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib24","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","article-title":"Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-B","volume":"25","author":"Price","year":"2005","journal-title":"J.\u00a0Cereb. Blood. Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib25","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.2011.381","article-title":"Plasma clusterin and the risk of Alzheimer disease","volume":"305","author":"Schrijvers","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib26","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib27","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.2009.1913","article-title":"Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial","volume":"302","author":"Snitz","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2009.06.073","article-title":"Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairments but not with Alzheimer's disease","volume":"462","author":"Solomon","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuroimage.2011.07.056","article-title":"Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment","volume":"59","author":"Thambisetty","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","article-title":"Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease","volume":"67","author":"Thambisetty","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2013.09.040_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J.\u00a0Intern. Med."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013004521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013004521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:22:58Z","timestamp":1759317778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013004521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0197458013004521"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.09.040","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of cholesterol transport are associated with amyloid deposition in the brain","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}